GAMMA Investing »

Avalo Therapeutics Ord shares owned by GAMMA Investing

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-09-30 $2.9k 189 15.33

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Micron Technology Common Stock (MU)
Eli Lilly Common Stock (LLY)
Advanced Micro Devices Common Stock (AMD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Tesla Common Stock (TSLA)

View all positions for GAMMA Investing

Top funds holding Avalo Therapeutics Ord

FMR
BlackRock
Deep Track Capital
Caligan Partners
TCG Crossover Management
Affinity Asset Advisors
State Street Corporation
Farallon Capital Management
Point72 Asset Management
venBio Select Advisor
Vanguard Capital Management
BVF
Bank of America Corporation
Nantahala Capital Management
Adage Capital Partners GP

View all funds holding Avalo Therapeutics Ord